IP_Asset's profile picture. Commercial IP and healthcare translation experts - accelerating patient benefit and commercial outcomes through accessible development, analysis & intelligence

IP Asset Ventures

@IP_Asset

Commercial IP and healthcare translation experts - accelerating patient benefit and commercial outcomes through accessible development, analysis & intelligence

You might like
IP Asset Ventures reposted

Researchers use a single molecule to command stem cells to build new bone ow.ly/swGe5045H21


IP Asset Ventures reposted

Online Now: risk stratification for drug cardiotoxicity using patient-derived iPSCs, Wu lab cell.com/cell-stem-cell…

CellStemCell's tweet image. Online Now: risk stratification for drug cardiotoxicity using patient-derived iPSCs, Wu lab cell.com/cell-stem-cell…

IP Asset Ventures reposted

#Philogen targets #angiogenesis for cancer and Autoimmune Therapies ow.ly/P8X3302IQPE

Labiotech_eu's tweet image. #Philogen targets #angiogenesis for cancer and Autoimmune Therapies ow.ly/P8X3302IQPE

IP Asset Ventures reposted

.@AstraZeneca plans Phase I trial with #mRNAtherapy for Cardiovascular Disease ow.ly/MIkN302Gu7i

Labiotech_eu's tweet image. .@AstraZeneca plans Phase I trial with #mRNAtherapy for Cardiovascular Disease ow.ly/MIkN302Gu7i

IP Asset Ventures reposted

German Biotech raises extra €31M to get first-in-class Antibody through trials #InflarX ow.ly/O9et302zU1X

Labiotech_eu's tweet image. German Biotech raises extra €31M to get first-in-class Antibody through trials #InflarX ow.ly/O9et302zU1X

IP Asset Ventures reposted

Here’s 14 Biotechs in #Scotland: From Biodefense to whisky-based #Biofuels ow.ly/2Zd0302nJ2I

Labiotech_eu's tweet image. Here’s 14 Biotechs in #Scotland: From Biodefense to whisky-based #Biofuels  ow.ly/2Zd0302nJ2I

IP Asset Ventures reposted

Winner Antibody’ holds promise as universal Influenza A Vaccine @MedImmunehttp://ow.ly/4k1B302uLrg

Labiotech_eu's tweet image. Winner Antibody’ holds promise as universal Influenza A Vaccine @MedImmunehttp://ow.ly/4k1B302uLrg

IP Asset Ventures reposted

Storm on the Car-T field – 3 patients die in Phase II Study #Cancer #Cellectis ow.ly/nXkI302788E

Labiotech_eu's tweet image. Storm on the Car-T field – 3 patients die in Phase II Study #Cancer #Cellectis ow.ly/nXkI302788E

IP Asset Ventures reposted

French Startup #Horama raised €4M for #GeneTherapy to fix specific Types of #Blindness ow.ly/qXzl3022Vrx

Labiotech_eu's tweet image. French Startup #Horama raised €4M for #GeneTherapy to fix specific Types of #Blindness ow.ly/qXzl3022Vrx

IP Asset Ventures reposted

Key German Hospital and @MedigeneAG to start a Phase I trial in TCR Cell Therapy #cancer ow.ly/TKi9301PSel

Labiotech_eu's tweet image. Key German Hospital and @MedigeneAG to start a Phase I trial in TCR Cell Therapy #cancer ow.ly/TKi9301PSel

IP Asset Ventures reposted

Novel Antibiotic for Resistant #bacteria gets a €22M Push from Key Investors #Allecra ow.ly/DcJk301mhib

Labiotech_eu's tweet image. Novel Antibiotic for Resistant #bacteria gets a €22M Push from Key Investors #Allecra ow.ly/DcJk301mhib

Extracellular vesicles, the next Minions? Read more at signalsblog.ca/extracellular-…

IP_Asset's tweet image. Extracellular vesicles, the next Minions? Read more at signalsblog.ca/extracellular-…

IP Asset Ventures reposted

#Immunotherapy reaches Breakthrough in eliminating #HIV @Immunocore ow.ly/6gLa301cFcL

Labiotech_eu's tweet image. #Immunotherapy reaches Breakthrough in eliminating #HIV @Immunocore ow.ly/6gLa301cFcL

IP Asset Ventures reposted

Novel Antibiotic for Resistant #bacteria gets a €22M Push from Key Investors #Allecra ow.ly/DcJk301mhib

Labiotech_eu's tweet image. Novel Antibiotic for Resistant #bacteria gets a €22M Push from Key Investors #Allecra ow.ly/DcJk301mhib

IP Asset Ventures reposted

Influencing the infant #microbiome: The impact of #antibiotic treatment: ow.ly/fds0301klcD

GENbio's tweet image. Influencing the infant #microbiome: The impact of #antibiotic treatment:  ow.ly/fds0301klcD

IP Asset Ventures reposted

New Biomarkers could make Personalized Medicine for #Depression @KingsCollegeLon ow.ly/OFUT301eBEV

Labiotech_eu's tweet image. New Biomarkers could make Personalized Medicine for #Depression @KingsCollegeLon ow.ly/OFUT301eBEV

IPAV mentor & judge in health tech competition termis.org/eu2016/bpc.php

IP_Asset's tweet image. IPAV mentor & judge in health tech competition termis.org/eu2016/bpc.php

IP Asset Ventures reposted

Japan sets safety standards for iPS cell transplants via @NAR. #stemcells #clinicaltrial #Japan s.nikkei.com/1WWPU21


IP Asset Ventures reposted

This week's GEN List spotlights the Top Eight Asia Biopharma Clusters 2016: ow.ly/g5e9300L2OG

GENbio's tweet image. This week's GEN List spotlights the Top Eight Asia Biopharma Clusters 2016: ow.ly/g5e9300L2OG

IP Asset Ventures reposted

For struggling pharma market, #vaccines offer path to revenue; $45.1B projected by 2022: ow.ly/xi8b300pCFZ

GENbio's tweet image. For struggling pharma market, #vaccines offer path to revenue; $45.1B projected by 2022: ow.ly/xi8b300pCFZ

Loading...

Something went wrong.


Something went wrong.